|
|
|
|
|
|
- ABB has won a contract worth more than US$210 million from the Algerian oil and gas company Sonatrach to expand existing compressor and power systems, enabling increased gas exports to Europe |
|
|
|
- ConocoPhillips has awarded Aker Kvaerner a service contract for provision of personnel and equipment for well intervention services on the Norwegian Continental Shelf |
|
|
|
- The Katadyn 'Survivor' Watermaker units are hand-operated desalinators that use reverse osmosis techniques to provide emergency fresh drinking water from sea water |
|
|
|
- Elfab, the leading European manufacturer of pressure-relief systems, has appointed Marjorie de Backer as its Territory Sales Manager to cover France |
|
|
|
- The Aker Kvaerner sale of its Pulping and Power businesses to the Metso Corporation has been approved by the European Commission: transaction closing date set for 31 December |
|
|
|
- Badger Meter control valves from Pump Engineering provide the answer to critical process control valve challenges across a wide range of industries, with special body materials and seals available |
|
|
|
- Foster Wheeler has been awarded a FEED and project management consultancy contract by the PTT Public Company for its sixth gas separation plant, GSP6, which will be located at Rayong, Thailand |
|
|
|
- 2006 has been a highly competitive year for the fluid handling equipment industry, and although some companies have been enjoying historically high margins, 2007 promises ever tougher times |
|
|
|
- Sealed Air is mounting a major marketing campaign aimed at persuading a diverse range of UK food and beverage companies to follow a lead being set by drinks producers north of the border |
|
|
|
- Robert Speziale entrusted to ensure a balance between the interests of commercial vendors and the research and development community, in role of Chair of the SBS Partners in Commerce Committee |
|
|
|
- The use of a light-weight, long reach robotic manipulator has allowed engineering specialists INS to help British Nuclear Group maximise the capacity of two bulk storage tanks in SIXEP at Sellafield |
|
|
|
- The Dynasonics TFXP portable transit time flow meter features the most advanced measurement technology, providing unsurpassed accuracy, versatility, ease of installation and dependability |
|
|
|
- A new Flender gear unit in a Lancashire based packaging company replaced an unreliable unit, for less than the refurbishment cost, reduced energy costs, and is proving itself far more reliable too |
|
|
|
- As the Sales Operations Manager, you will be providing sales process support (orders, escalations, resources), sales reports and analysis (demand planning and forecasting) and other general operations management activities. Work is performed with minimal direction and reviewed by senior management. This position will report directly to the VP of Sales. Responsibilities: * Formulating and tracking quotes * Handling POs and RMAs * Shipping interaction * Forecasting and demand planning * Keeping track of bookings, backlog, revenues, and timeliness of deliveries. |
|
|
|
- Job Description : Candidate will be responsible for pulling new tunable laser subsystems designs into manufacture via the New Product Introduction Process, interfacing with the circuit board CM, and supporting products currently in production. Responsibilities: * Responsible for developing, improving, and supporting existing electronic module assembly processes in production * Ownership of module assembly processes, interface with PCB CM, and SPC, yield, cost, and capacity associated with the electronic module assembly processes. |
|
|
|
- Rittal introduces a new range of backplanes that meet the PCI Industrial Computer Manufacturers Group (PICMG) 2.16 specification. |
|
|
|
- Abacus Group has been named as the Harting number one distributor for the fourth year in succession |
|
|
|
- Versatile, dependable and cost-effective power supplies with output currents of up to 3A can be implemented easily and conveniently using the new XC9220/XC9221 range of step-down DC/DC controller ICs |
|
|
|
- At CES 2007, Cambridge Consultants will launch a platform design which rewrites the economics of the emerging internet radio market. |
|
|
|
- Radstone Sensor Processing has announced at Undersea Defence Technology (UDT) Pacific 2006 the revolutionary DaqNet fully integrated acoustic data acquisition/conversion system. |
|
|
|
- 3M Touch Systems announces the demonstration of a new touch screen system, the Microtouch capacitive touchsense system |
|
|
|
- Teradyne and Staccato Communications have jointly announced that the Flex Test Platform has been specified for the production ramp of Staccato's Ripcord product family based on Certified Wireless USB. |
|
|
|
- Mazet presents two unique OEM true-colour sensor modules under the name MTCS-TIAM. |
|
|
|
- Eleksen has been chosen by the Consumer Electronics Association as an International CES Innovations 2007 Design and Engineering Awards Honouree for its iPod controller. |
|
|
|
- After a decade of being ISO 9001 approved, Fascia Graphics, which produces membrane keypads in the printed graphics industry, has achieved another three year ISO 9001:2000 accreditation. |
|
|
|
- TTTech Computertechnik has announced a strengthening of the company for further international expansion. |
|
|
|
- Among people suffering from chronic cough, more than half have symptoms of depression, new research shows. The good news is that the depression seems to lift as the cough improves. Cough is the most common reason people in the US seek medical attention, and several reports have shown that chronic cough can have a… read this story at Reuters Health News. |
|
|
|
- Seoul Semiconductor introduces the P4 Z-Power LED, which delivers 100 lumen/watt brightness. The P4 emits 240 lm at 1 A of light and features 100 lm/W at 350 mA at the maximum. The LED is based only on a single die. “P4 is making history in the ... |
|
|
|
- ETonline - Four adult-film actresses head to London to take on Shakespeare! |
|
|
|
- Ka?dy zapewne zapami?ta? co robi? 13 grudnia 1981 roku. |
|
|
|
- A new travel insurance product that offers people with asthma the chance to buy cover at an affordable price has been developed by Unique Insurance and Asthma UK. This new scheme is now available online so getting a quote is easy. There is also a 5% discount for policies purchased online. [click link for full article] |
|
|
|
- Teri Brentnall, MD, of the University of Washington, today announced the breakthrough discovery of a gene, which, when mutated, causes pancreatic cancer in families. This discovery may allow for earlier detection of the disease as well as for intervention in patients who are at a high-risk because two or more members of their family have the disease. [click link for full article] |
|
|
|
- CuraGen Corporation (Nasdaq: CRGN) and TopoTarget A/S announced today updated Phase II MM results on PXD101, a small molecule histone deacetylase (HDAC) inhibitor, were presented at the American Society of Hematology (ASH) Annual Meeting in Orlando, Florida, December 10 to 13, 2006. [click link for full article] |
|
|
|
- NeuroVasx, Inc. is developing its cPAX aneurysm Treatment System to meet the need for a better, more cost effective solution for the minimally invasive treatment of cerebral aneurysms. A cerebral aneurysm is an abnormal bulge or sac in the wall of an artery in the brain. If ruptured, the aneurysm can result in massive intracranial bleeding and often lead to death. [click link for full article] |
|
|
|
- Northern Therapeutics, Inc., a Canadian biotechnology company, and MaxCyte, Inc., a U.S. therapeutics company, announced today the commencement of the first-ever human trial of a novel, engineered cell-based therapy for the treatment of idiopathic (primary) pulmonary arterial hypertension (PAH), a rare but fatal cardiovascular disease that can strike in the prime of a person's life. |
|
|
|
- EntreMed, Inc. [click link for full article] |
|
|
|
- Avicena Group, Inc. (OTC Bulletin Board: AVGO), a biotechnology company focused on commercializing its proprietary cellular energy modulation technology, announced today the initiation of a chronic toxicology study of HD-02, its lead candidate for Huntington's disease (HD). [click link for full article] |
|
|
|
- Bristol-Myers Squibb Company (NYSE: BMY) and Otsuka Pharmaceutical Co., Ltd. today announced the launch of ABILIFY(R) (aripiprazole) Injection, an injectable form of ABILIFY, for intramuscular use. ABILIFY Injection provides rapid control of agitation in adults with schizophrenia or bipolar mania at primary endpoint (2 hours). |
|
|
|
- ZymoGenetics, Inc. (Nasdaq: ZGEN) today presented results from two Phase 1b studies in patients with non-Hodgkin's lymphoma (NHL) and multiple myeloma (MM) at the American Society of Hematology (ASH) annual meeting. Treatment with atacicept was well tolerated and drug activity was demonstrated by consistent biologic marker responses. [click link for full article] |
|
|
|
- An independent working group chaired by Sir David Weatherall, has concluded that there is a scientific case for careful, meticulously regulated non-human primate research, at least for the foreseeable future, provided it is the only way of solving important scientific or medical questions and high standards of welfare are maintained. [click link for full article] |
|
|
|
- Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM) today reported the presentation of results of several clinical trials of VELCADE(R) (bortezomib) for Injection in combination with a variety of agents, including DOXIL(R) (pegylated liposomol doxorubicin) and dexamethasone, for the treatment of newly diagnosed multiple myeloma (MM) patients. [click link for full article] |
|
|
|
- Scott Gottlieb, MD, Deputy Commissioner for Medical and Scientific Affairs at the Food and Drug Administration announced today that he will leave the agency effective January 16, 2007, to return to the American Enterprise Institute, a Washington-based think tank where he was previously a Resident Fellow prior to joining FDA.Dr. Gottlieb joined FDA as Deputy Commissioner in July 2005. [click link for full article] |
|
|
|
- The Food and Drug Administration (FDA) today proposed significant regulatory changes to make experimental drugs more widely and easily available to seriously ill patients with no other treatment options and to clarify the circumstances and the costs for which a manufacturer can charge for an experimental drug. [click link for full article] |
|
|
|
- Lung Rx, Inc., a wholly-owned subsidiary of United Therapeutics Corporation (Nasdaq: UTHR), announced that its Canadian affiliate, Northern Therapeutics, Inc., has commenced the first-ever human trial of a novel, cell-mediated gene therapy for the treatment of pulmonary arterial hypertension. The first patient in the trial received therapy at St. |
|
